Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014191605> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3014191605 abstract "Purpose Respiratory tract infection with respiratory syncytial virus (RSV), human metapneumo virus (hMPV) or parainfluenza virus (PIV) are increasingly associated with chronic lung allograft dysfunction in the form of bronchiolitis obliterans syndrome (BOS) in lung transplant recipients (LTR). Ribavirin as treatment option is under debate since its effectiveness is unclear, especially in light of infection severity. Methods We retrospectively analyzed 10 years of RSV, hMPV and PIV infections in LTR in our center. Main endpoints were FEV1 at 3 and 6 months post-infection, expressed as a percentage of pre-infection FEV1 (by hierarchical linear mixed model) and incidence of new or progressed BOS 6 months post infection (by logistic regression). Patients with acute rejection Results A total of 139 infections were included, 88 (63%) with a severe infection (defined as a >10% FEV1 decline at infection), and 51 (37%) with a mild infection (≤10% FEV decline). Median [IQR] FEV1 decline during infection was notable and similar across the viruses (RSV 14% [22], hMPV 15% [14], PIV 16% [20]. Overall post-infection BOS incidence was 20% (27% for severe, 10% for mild). There were no virus related deaths. The linear mixed model found estimated associations on post-infection FEV1 for ribavirin treatment vs. no ribavirin (+13.2% [7.79;18.67]) and severe infection vs. mild infection (-11.1% [-14.76; -7.37). Ribavirin treatment (aOR 0.24 [0.10-0.59]), severe infection (aOR 4.63 [1.66;12.88]) and surprisingly also MMF use (aOR 0.38 [0.14;0.97]) were factors associated with new or progressed BOS at 6 months. LTR with a mild infection tended to recover well, regardless of antiviral therapy. Conclusion We conclude that ribavirin should be considered as treatment option to possibly prevent allograft dysfunction in LTR with severe RSV, hMPV or PIV infection. We found no reason to discontinue MMF during these infections." @default.
- W3014191605 created "2020-04-10" @default.
- W3014191605 creator A5000820066 @default.
- W3014191605 creator A5003929307 @default.
- W3014191605 creator A5003941046 @default.
- W3014191605 creator A5003964087 @default.
- W3014191605 creator A5013428765 @default.
- W3014191605 creator A5036778007 @default.
- W3014191605 creator A5063300754 @default.
- W3014191605 creator A5067762033 @default.
- W3014191605 date "2020-04-01" @default.
- W3014191605 modified "2023-09-23" @default.
- W3014191605 title "Ten Years of Ribavirin Treatment for Pneumovirus and Paramyxovirus Infections in Lung Transplant Recipients" @default.
- W3014191605 doi "https://doi.org/10.1016/j.healun.2020.01.813" @default.
- W3014191605 hasPublicationYear "2020" @default.
- W3014191605 type Work @default.
- W3014191605 sameAs 3014191605 @default.
- W3014191605 citedByCount "0" @default.
- W3014191605 crossrefType "journal-article" @default.
- W3014191605 hasAuthorship W3014191605A5000820066 @default.
- W3014191605 hasAuthorship W3014191605A5003929307 @default.
- W3014191605 hasAuthorship W3014191605A5003941046 @default.
- W3014191605 hasAuthorship W3014191605A5003964087 @default.
- W3014191605 hasAuthorship W3014191605A5013428765 @default.
- W3014191605 hasAuthorship W3014191605A5036778007 @default.
- W3014191605 hasAuthorship W3014191605A5063300754 @default.
- W3014191605 hasAuthorship W3014191605A5067762033 @default.
- W3014191605 hasConcept C120665830 @default.
- W3014191605 hasConcept C121332964 @default.
- W3014191605 hasConcept C126322002 @default.
- W3014191605 hasConcept C203014093 @default.
- W3014191605 hasConcept C2522874641 @default.
- W3014191605 hasConcept C2776012195 @default.
- W3014191605 hasConcept C2776399701 @default.
- W3014191605 hasConcept C2776408679 @default.
- W3014191605 hasConcept C2776739411 @default.
- W3014191605 hasConcept C2777714996 @default.
- W3014191605 hasConcept C2778821649 @default.
- W3014191605 hasConcept C2780040827 @default.
- W3014191605 hasConcept C2781448352 @default.
- W3014191605 hasConcept C534529494 @default.
- W3014191605 hasConcept C61511704 @default.
- W3014191605 hasConcept C71924100 @default.
- W3014191605 hasConceptScore W3014191605C120665830 @default.
- W3014191605 hasConceptScore W3014191605C121332964 @default.
- W3014191605 hasConceptScore W3014191605C126322002 @default.
- W3014191605 hasConceptScore W3014191605C203014093 @default.
- W3014191605 hasConceptScore W3014191605C2522874641 @default.
- W3014191605 hasConceptScore W3014191605C2776012195 @default.
- W3014191605 hasConceptScore W3014191605C2776399701 @default.
- W3014191605 hasConceptScore W3014191605C2776408679 @default.
- W3014191605 hasConceptScore W3014191605C2776739411 @default.
- W3014191605 hasConceptScore W3014191605C2777714996 @default.
- W3014191605 hasConceptScore W3014191605C2778821649 @default.
- W3014191605 hasConceptScore W3014191605C2780040827 @default.
- W3014191605 hasConceptScore W3014191605C2781448352 @default.
- W3014191605 hasConceptScore W3014191605C534529494 @default.
- W3014191605 hasConceptScore W3014191605C61511704 @default.
- W3014191605 hasConceptScore W3014191605C71924100 @default.
- W3014191605 hasLocation W30141916051 @default.
- W3014191605 hasOpenAccess W3014191605 @default.
- W3014191605 hasPrimaryLocation W30141916051 @default.
- W3014191605 hasRelatedWork W11591070 @default.
- W3014191605 hasRelatedWork W11871960 @default.
- W3014191605 hasRelatedWork W12802298 @default.
- W3014191605 hasRelatedWork W12955278 @default.
- W3014191605 hasRelatedWork W1779668 @default.
- W3014191605 hasRelatedWork W3575872 @default.
- W3014191605 hasRelatedWork W5138191 @default.
- W3014191605 hasRelatedWork W5251251 @default.
- W3014191605 hasRelatedWork W546280 @default.
- W3014191605 hasRelatedWork W7059789 @default.
- W3014191605 isParatext "false" @default.
- W3014191605 isRetracted "false" @default.
- W3014191605 magId "3014191605" @default.
- W3014191605 workType "article" @default.